Bumper Offer - Urjas oil Just @ Rs. 1
Olkem 20 H Tablet (15) is a prescription drug, available for use as Tablet. The alternative uses of Olkem 20 H Tablet (15) have also been explained below.
The optimal dosage of Olkem 20 H Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Olkem 20 H Tablet (15) include Upper respiratory tract infection. Some other side effects of Olkem 20 H Tablet (15) have been listed ahead. Such side effects of Olkem 20 H Tablet (15) normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Olkem 20 H Tablet (15) is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Olkem 20 H Tablet (15) related warnings talks about Olkem 20 H Tablet (15)'s effects on the liver, heart and kidney.
Olkem 20 H Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olkem 20 H Tablet (15) in conditions like Asthma, Allergy, Kidney Disease. Some other conditions that can be affected by Olkem 20 H Tablet (15) are listed in the contraindications section below.
Besides this, Olkem 20 H Tablet (15) may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Olkem 20 H Tablet (15) is not safe while driving, and is is not addictive in nature.
Olkem 20 H Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olkem 20 H Tablet (15) is used -
Moderate
Mild
Is the use of Olkem 20 H Tablet (15) safe for pregnant women?
Olkem H can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Olkem 20 H Tablet (15) safe during breastfeeding?
Olkem H may have very limited harmful effects for breastfeeding women.
What is the effect of Olkem 20 H Tablet (15) on the Kidneys?
Olkem H may have mild side effects on the kidneys.
What is the effect of Olkem 20 H Tablet (15) on the Liver?
Olkem H is rarely harmful for the liver.
What is the effect of Olkem 20 H Tablet (15) on the Heart?
Very few cases of side effects of Olkem H on the heart have been reported.
Olkem 20 H Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olkem 20 H Tablet (15) unless your doctor advises you to do so -
Is this Olkem 20 H Tablet (15) habit forming or addictive?
Olkem 20 H Tablet (15) is not addictive in nature.
Interaction between Food and Olkem 20 H Tablet (15)
Some foods when eaten with Olkem 20 H Tablet (15) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olkem 20 H Tablet (15)
Consuming Olkem 20 H Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
